blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4190780

EP4190780 - METHOD FOR EXTRACTING MUPIROCIN [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  05.05.2023
Database last updated on 03.09.2024
FormerThe international publication has been made
Status updated on  05.03.2022
Most recent event   Tooltip17.08.2024Amendment by applicant 
Applicant(s)For all designated states
Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd.
866 Moganshan Road
GongShu District
HangZhou, Zhejiang 310011 / CN
[2023/23]
Inventor(s)01 / CHENG, Zhaobing
Hangzhou, Zhejiang 310011 / CN
02 / KOU, Guanghui
Hangzhou, Zhejiang 310011 / CN
03 / XU, Yiming
Hangzhou, Zhejiang 310011 / CN
04 / ZHANG, Kai
Hangzhou, Zhejiang 310011 / CN
05 / ZHANG, Yuchen
Hangzhou, Zhejiang 310011 / CN
 [2023/23]
Representative(s)HGF
HGF Limited
1 City Walk
Leeds LS11 9DX / GB
[2023/23]
Application number, filing date21860138.311.08.2021
[2023/23]
WO2021CN111926
Priority number, dateCN20201086424325.08.2020         Original published format: CN202010864243
CN20201125858312.11.2020         Original published format: CN202011258583
[2023/23]
Filing languageZH
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2022042299
Date:03.03.2022
Language:ZH
[2022/09]
Type: A1 Application with search report 
No.:EP4190780
Date:07.06.2023
Language:EN
[2023/23]
Search report(s)International search report - published on:CN03.03.2022
(Supplementary) European search report - dispatched on:EP16.02.2024
ClassificationIPC:C07D407/06, A61K31/351
[2023/23]
CPC:
C07D407/06 (EP,IL,US); A61K31/351 (EP,IL); B01D11/0492 (US);
B01D15/08 (US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/23]
TitleGerman:VERFAHREN ZUR EXTRAKTION VON MUPIROCIN[2023/23]
English:METHOD FOR EXTRACTING MUPIROCIN[2023/23]
French:PROCÉDÉ D'EXTRACTION DE MUPIROCINE[2023/23]
Entry into regional phase01.03.2023Translation filed 
01.03.2023National basic fee paid 
01.03.2023Search fee paid 
01.03.2023Designation fee(s) paid 
01.03.2023Examination fee paid 
Examination procedure01.03.2023Examination requested  [2023/23]
14.08.2024Amendment by applicant (claims and/or description)
14.08.2024Date on which the examining division has become responsible
Fees paidRenewal fee
01.03.2023Renewal fee patent year 03
18.07.2024Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XY]JPS5270083  (YOSHITOMI PHARMACEUTICAL) [X] 10 * abstract * * examples 1-3 * * claim 1 * [Y] 1-9;
 [IY]US4222942  (O'HANLON PETER J, et al) [I] 10 * abstract * * examples 1, 2 * * claims 1-9 * [Y] 1-9;
 [XA]US4289703  (BARROW KEVIN D, et al) [X] 10 * abstract * * examples 1-5 * * claim 1 *[A] 1-9;
 [XY]WO0046388  (BIOGAL GYOGYSZERGYAR [HU], et al) [X] 10 * abstract * * examples 2, 4 * * claims 1-17 * [Y] 1-9;
 [XA]US2004224981  (JANJIC NEBOJSA [US], et al) [X] 10 * abstract * * tables 1-4 * * examples 1-22 * * claims 1-24 * [A] 1-9;
 [IA]WO2008025534  (ALPHARMA APS [DK], et al) [I] 10 * abstract * * examples 1, 2 * * claims 1-30 * [A] 1-9;
 [XY]CN101591333  (BEIJING BIOLEADER BIOTECHNOLOG [CN]) [X] 10 * abstract * * page 6 * * examples 1-3 * * claims 1-10 * [Y] 1-9;
 [XY]CN110606844  (UNIV PEKING FOUNDER GROUP CO, et al) [X] 10 * abstract * * examples 1-3 * * claims 1-10 * [Y] 1-9
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.